收稿日期: 2023-03-26
录用日期: 2023-09-15
网络出版日期: 2023-10-28
Advances in preoperative medical management of metabolic surgery
Received date: 2023-03-26
Accepted date: 2023-09-15
Online published: 2023-10-28
肥胖是一种慢性代谢性疾病,其人数日益增多,已成为包括中国在内的许多国家的重要公共卫生问题和流行病。肥胖及其合并症如2型糖尿病(type 2 diabetes mellitus,T2DM)、非酒精性脂肪肝、高血压和心血管疾病等严重危害生命健康。随着代谢手术的不断发展和完善,其作为一种安全、有效的治疗肥胖及其合并症的方法,已被广泛应用于肥胖患者的临床治疗中。代谢手术可以帮助患者显著减轻体质量,改善代谢指标,降低糖尿病、高血压等慢性病的风险,改善患者的生活质量,为患者带来全面的健康益处。然而,目前临床上缺乏规范的代谢手术术前内科管理,可能导致患者出现代谢紊乱、营养缺乏等并发症,从而增加手术风险和术后并发症发生率,影响减重的效果,对患者的预后造成不良影响。该文回顾了代谢手术术前减重、血糖控制、血压和血脂控制、微量营养素补充、心理和行为调节等方面的相关文献,对代谢手术术前内科管理进行综述,旨在为有效提高代谢手术的安全性和治疗效果,以及改善患者的预后提供参考。
单颖仪 , 于浩泳 . 代谢手术术前内科管理进展[J]. 上海交通大学学报(医学版), 2023 , 43(10) : 1332 -1338 . DOI: 10.3969/j.issn.1674-8115.2023.10.016
Obesity is a chronic metabolic disease that is increasing in prevalence and has become a major public health problem and epidemic in many countries, including China. Obesity and its associated complications, such as type 2 diabetes (T2DM), non-alcoholic fatty liver disease, hypertension, and cardiovascular disease, seriously damage health. With the continuous development of metabolic surgery, it has become a widely used, safe and effective method for treating obesity and its associated complications. Metabolic surgery can significantly lose weight, improve metabolic indicators, reduce the risk of chronic diseases such as diabetes and hypertension, improve the quality of life of patients, and bring comprehensive health benefits to patients. However, there is currently a lack of standardized preoperative medical management for metabolic surgery, which may lead to metabolic disorders, nutrient deficiencies, and other complications, increasing the risk of surgery and postoperative complications, and affecting the efficacy of weight loss and the prognosis of patients. Through the systematic review of literature related to preoperative weight loss, glycemic control, blood pressure and lipid control, micronutrient supplementation, and psychological and behavioral modifications, this paper reviews preoperative medical management of metabolic surgery with the aim of providing reference for effectively improving the safety and efficacy of metabolic surgery and improving the prognosis of patients.
Key words: metabolic surgery; obesity; diabetes; medical management
1 | World Health Organization. Obesity and overweight[EB/OL]. (2021-06-09) [2023-03-28]. https://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight. |
2 | WANG L, ZHOU B, ZHAO Z, et al. Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004-18[J]. Lancet, 2021, 398(10294): 53-63. |
3 | ADAMS T D, DAVIDSON L E, LITWIN S E, et al. Weight and metabolic outcomes 12 years after gastric bypass[J]. N Engl J Med, 2017, 377(12): 1143-1155. |
4 | SCHAUER P R, BHATT D L, KIRWAN J P, et al. Bariatric surgery versus intensive medical therapy for diabetes: 5-year outcomes[J]. N Engl J Med, 2017, 376(7): 641-651. |
5 | MINGRONE G, PANUNZI S, DE GAETANO A, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial[J]. Lancet, 2021, 397(10271): 293-304. |
6 | SYN N L, CUMMINGS D E, WANG L Z, et al. Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants[J]. Lancet, 2021, 397(10287): 1830-1841. |
7 | ANGRISANI L, SANTONICOLA A, IOVINO P, et al. Bariatric surgery survey 2018: similarities and disparities among the 5 IFSO chapters[J]. Obes Surg, 2021, 31(5): 1937-1948. |
8 | DU X, DAI R, ZHOU H X, et al. Bariatric surgery in China: how is this new concept going?[J]. Obes Surg, 2016, 26(12): 2906-2912. |
9 | EISENBERG D, SHIKORA S A, AARTS E, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): indications for metabolic and bariatric surgery[J]. Surg Obes Relat Dis, 2022, 18(12): 1345-1356. |
10 | 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华内分泌代谢杂志, 2021, 37(4): 311-398. |
10 | Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition) [J]. Chinese Journal of Endocrinology and Metabolism, 2021, 37(4): 311-398. |
11 | VAN WISSEN J, BAKKER N, DOODEMAN H J, et al. Preoperative methods to reduce liver volume in bariatric surgery: a systematic review[J]. Obes Surg, 2016, 26(2): 251-256. |
12 | KOUTOUKIDIS D A, KOSHIARIS C, HENRY J A, et al. The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: a systematic review and meta-analysis[J]. Metabolism, 2021, 115: 154455. |
13 | ROMAN M, MONAGHAN A, SERRAINO G F, et al. Meta-analysis of the influence of lifestyle changes for preoperative weight loss on surgical outcomes[J]. Br J Surg, 2019, 106(3): 181-189. |
14 | SAMAAN J S, ZHAO J, QIAN E, et al. Preoperative weight loss as a predictor of bariatric surgery postoperative weight loss and complications[J]. J Gastrointest Surg, 2022, 26(1): 86-93. |
15 | ANDERIN C, GUSTAFSSON U O, HEIJBEL N, et al. Weight loss before bariatric surgery and postoperative complications: data from the Scandinavian Obesity Registry (SOReg)[J]. Ann Surg, 2015, 261(5): 909-913. |
16 | SARNO G, CALABRESE P, FRIAS-TORAL E, et al. The relationship between preoperative weight loss and intra and post-bariatric surgery complications: an appraisal of the current preoperative nutritional strategies[J]. Crit Rev Food Sci Nutr, 2022: 1-9. |
17 | HUTCHEON D A, HALE A L, EWING J A, et al. Short-term preoperative weight loss and postoperative outcomes in bariatric surgery[J]. J Am Coll Surg, 2018, 226(4): 514-524. |
18 | TABESH M R, MALEKLOU F, EJTEHADI F, et al. Nutrition, physical activity, and prescription of supplements in pre- and post-bariatric surgery patients: a practical guideline[J]. Obes Surg, 2019, 29(10): 3385-3400. |
19 | WOLF R M, OSHIMA K, CANNER J K, et al. Impact of a preoperative low-calorie diet on liver histology in patients with fatty liver disease undergoing bariatric surgery[J]. Surg Obes Relat Dis, 2019, 15(10): 1766-1772. |
20 | LEAN M E J. Low-calorie diets in the management of type 2 diabetes mellitus[J]. Nat Rev Endocrinol, 2019, 15(5): 251-252. |
21 | STEVEN S, HOLLINGSWORTH K G, AL-MRABEH A, et al. Very low-calorie diet and 6 months of weight stability in type 2 diabetes: pathophysiological changes in responders and nonresponders[J]. Diabetes Care, 2016, 39(5): 808-815. |
22 | PARRETTI H M, JEBB S A, JOHNS D J, et al. Clinical effectiveness of very-low-energy diets in the management of weight loss: a systematic review and meta-analysis of randomized controlled trials[J]. Obes Rev, 2016, 17(3): 225-234. |
23 | GASTALDO I, CASAS R, MOIZé V. Clinical impact of Mediterranean diet adherence before and after bariatric surgery: a narrative review[J]. Nutrients, 2022, 14(2): 393. |
24 | TETTAMANZI F, BAGNARDI V, LOUCA P, et al. A high protein diet is more effective in improving insulin resistance and glycemic variability compared to a Mediterranean diet: a cross-over controlled inpatient dietary study[J]. Nutrients, 2021, 13(12): 4380. |
25 | VICENTE MARTIN C, RABAGO TORRE L R, CASTILLO HERRERA L A, et al. Preoperative intragastric balloon in morbid obesity is unable to decrease early postoperative morbidity of bariatric surgery (sleeve gastrectomy and gastric bypass): a clinical assay[J]. Surg Endosc, 2020, 34(6): 2519-2531. |
26 | SARI C, SEIP R L, UMASHANKER D. Case report: off label utilization of topiramate and metformin in patients with BMI ≥50 kg/m2 prior to bariatric surgery[J]. Front Endocrinol (Lausanne), 2021, 12: 588016. |
27 | GADDE K M, MARTIN C K, BERTHOUD H R, et al. Obesity: pathophysiology and management[J]. J Am Coll Cardiol, 2018, 71(1): 69-84. |
28 | AMINIAN A, BRETHAUER S A, ANDALIB A, et al. Individualized metabolic surgery score: procedure selection based on diabetes severity[J]. Ann Surg, 2017, 266(4): 650-657. |
29 | JONES C E, GRAHAM L A, MORRIS M S, et al. Association between preoperative hemoglobin A1c levels, postoperative hyperglycemia, and readmissions following gastrointestinal surgery[J]. JAMA Surg, 2017, 152(11): 1031-1038. |
30 | HART A, GOFFREDO P, CARROLL R, et al. Optimizing bariatric surgery outcomes: the impact of preoperative elevated hemoglobin A1c levels on composite perioperative outcome measures[J]. Surg Endosc, 2021, 35(8): 4618-4623. |
31 | American Diabetes Association Professional Practice Committee. 16. diabetes care in the hospital: standards of medical care in diabetes-2022[J]. Diabetes Care, 2022, 45(Suppl 1): S244-S253. |
32 | SIMHA V, SHAH P. Perioperative glucose control in patients with diabetes undergoing elective surgery[J]. JAMA, 2019, 321(4): 399-400. |
33 | MOREY-VARGAS O L, AMINIAN A, STECKNER K, et al. Perioperative management of diabetes in patients undergoing bariatric and metabolic surgery: a narrative review and the Cleveland Clinic practical recommendations[J]. Surg Obes Relat Dis, 2022, 18(8): 1087-1101. |
34 | MULLA C M, BALOCH H M, HAFIDA S. Management of diabetes in patients undergoing bariatric surgery[J]. Curr Diab Rep, 2019, 19(11): 112. |
35 | COURCOULAS A P, KING W C, BELLE S H, et al. Seven-year weight trajectories and health outcomes in the longitudinal assessment of bariatric surgery (LABS) study[J]. JAMA Surg, 2018, 153(5): 427-434. |
36 | HAYOZ C, HERMANN T, RAPTIS D A, et al. Comparison of metabolic outcomes in patients undergoing laparoscopic roux-en-Y gastric bypass versus sleeve gastrectomy: a systematic review and meta-analysis of randomised controlled trials[J]. Swiss Med Wkly, 2018, 148: w14633. |
37 | 中国血脂管理指南修订联合专家委员会. 中国血脂管理指南(2023年)[J]. 中华心血管病杂志, 2023, 51(3): 221-255. |
37 | Joint Committee on the Chinese Guidelines for Lipid Management. Chinese guidelines for lipid management (2023)[J]. Chinese Journal of Cardiology, 2023, 51(3): 221-255. |
38 | GUAN B S, YANG J G, CHEN Y Y, et al. Nutritional deficiencies in Chinese patients undergoing gastric bypass and sleeve gastrectomy: prevalence and predictors[J]. Obes Surg, 2018, 28(9): 2727-2736. |
39 | AL-MUTAWA A, ANDERSON A K, ALSABAH S, et al. Nutritional status of bariatric surgery candidates[J]. Nutrients, 2018, 10(1): 67. |
40 | BEN-PORAT T, ELAZARY R, YUVAL J B, et al. Nutritional deficiencies after sleeve gastrectomy: can they be predicted preoperatively?[J]. Surg Obes Relat Dis, 2015, 11(5): 1029-1036. |
41 | ENANI G, BILGIC E, LEBEDEVA E, et al. The incidence of iron deficiency anemia post-Roux-en-Y gastric bypass and sleeve gastrectomy: a systematic review[J]. Surg Endosc, 2020, 34(7): 3002-3010. |
42 | PARROTT J M, CRAGGS-DINO L, FARIA S L, et al. The optimal nutritional programme for bariatric and metabolic surgery[J]. Curr Obes Rep, 2020, 9(3): 326-338. |
43 | SHERF DAGAN S, GOLDENSHLUGER A, GLOBUS I, et al. Nutritional recommendations for adult bariatric surgery patients: clinical practice[J]. Adv Nutr, 2017, 8(2): 382-394. |
44 | PARROTT J, FRANK L, RABENA R, et al. American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the surgical weight loss patient 2016 update: micronutrients[J]. Surg Obes Relat Dis, 2017, 13(5): 727-741. |
45 | MOHAN S, SAMAAN J S, SAMAKAR K. Impact of smoking on weight loss outcomes after bariatric surgery: a literature review[J]. Surg Endosc, 2021, 35(11): 5936-5952. |
46 | INADOMI M, IYENGAR R, FISCHER I, et al. Effect of patient-reported smoking status on short-term bariatric surgery outcomes[J]. Surg Endosc, 2018, 32(2): 720-726. |
47 | WOOD G C, BENOTTI P N, LEE C J, et al. Evaluation of the association between preoperative clinical factors and long-term weight loss after Roux-en-Y gastric bypass[J]. JAMA Surg, 2016, 151(11): 1056-1062. |
48 | MALIK S, MITCHELL J E, ENGEL S, et al. Psychopathology in bariatric surgery candidates: a review of studies using structured diagnostic interviews[J]. Compr Psychiatry, 2014, 55(2): 248-259. |
49 | MüLLER M, NETT P C, BORBéLY Y M, et al. Mental illness has a negative impact on weight loss in bariatric patients: a 4-year follow-up[J]. J Gastrointest Surg, 2019, 23(2): 232-238. |
50 | CHAO A M, WADDEN T A, FAULCONBRIDGE L F, et al. Binge-eating disorder and the outcome of bariatric surgery in a prospective, observational study: two-year results[J]. Obesity (Silver Spring), 2016, 24(11): 2327-2333. |
51 | PEKKARINEN T, MUSTONEN H, SANE T M, et al. Long-term effect of gastric bypass and sleeve gastrectomy on severe obesity: do preoperative weight loss and binge eating behavior predict the outcome of bariatric surgery?[J]. Obes Surg, 2016, 26(9): 2161-2167. |
52 | FUCHS H F, LAUGHTER V, HARNSBERGER C R, et al. Patients with psychiatric comorbidity can safely undergo bariatric surgery with equivalent success[J]. Surg Endosc, 2016, 30(1): 251-258. |
53 | MECHANICK J I, APOVIAN C, BRETHAUER S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures—2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, the Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists[J]. Obesity (Silver Spring), 2020, 28(4): O1-O58. |
54 | CARTER J, CHANG J, BIRRIEL T J, et al. ASMBS position statement on preoperative patient optimization before metabolic and bariatric surgery[J]. Surg Obes Relat Dis, 2021, 17(12): 1956-1976. |
55 | MAREK R J, HEINBERG L J, LAVERY M, et al. A review of psychological assessment instruments for use in bariatric surgery evaluations[J]. Psychol Assess, 2016, 28(9): 1142-1157. |
/
〈 |
|
〉 |